Nizar J. Bahlis, MD, discusses updated data from the phase 3 MAIA trial in multiple myeloma.
Nizar J. Bahlis, MD
Advertisement
Articles by Nizar J. Bahlis, MD
Nizar J. Bahlis, MD, discusses updated data from the phase 3 MAIA trial in multiple myeloma.
Nizar J. Bahlis, MD, discusses daratumumab (Darzalex) plus lenalidomide (Revlimid) and dexamethasone in newly diagnosed multiple myeloma.
Advertisement
Latest Updated Articles
Dr. Bahlis on Daratumumab Plus Lenalidomide and Dexamethasone in Multiple MyelomaPublished: January 29th 2020 | Updated:
Dr. Bahlis on Updated Data From the MAIA Trial in Multiple MyelomaPublished: May 20th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5